Purification of antibodies using the synthetic affinity ligand absorbent mabsorbent a2p

Nature Protocols

Volumn 2, Issue 7, 2007, Pages 1763-1769

  Chhatre, Sunil ^a   Keshavarz Moore, Eli ^a   Newcombe, Anthony R ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b BIOCOMPATIBLES UK LTD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; LIGAND; MONOCLONAL ANTIBODY;

ABSORPTION; AFFINITY CHROMATOGRAPHY; ANIMAL; ARTICLE; BLOOD; ELECTROPHORESIS; FILTRATION; ISOLATION AND PURIFICATION; METHODOLOGY; SHEEP;

ABSORPTION; ANIMALS; ANTIBODIES; ANTIBODIES, MONOCLONAL; CHROMATOGRAPHY, AFFINITY; ELECTROPHORESIS; FILTRATION; LIGANDS; SHEEP;

EID: 34548549315     PISSN: 17542189     EISSN: 17502799     Source Type: Journal    
DOI: 10.1038/nprot.2007.253     Document Type: Article

References (16)

1. Harlow, E. and Lane, D.: Antibodies: A Laboratory Manual (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1988).
2. Newcombe, C. and Newcombe, A.R.: Antibody production: polyclonal-derived biotherapeutics. J. Chromatogr. B 848, 2-7 (2007).
3. Thillaivinayagalingam, P., O'Donovan, K., Newcombe, A.R. and Keshavarz-Moore, E.: Characterisation of an industrial affinity process used in the manufacturing of digoxin-specific polyclonal Fab fragments. J. Chromatogr. B 848, 88-96 (2007).
4. Racher, A.J., Tong, J.M. and Bonnerjea, J.: Biotechnology. Recombinant Proteins Vol. 5a 247 (Wiley-VCH, Weinheim, Germany, 2003).
5. Lian, L.Y., Barsukov, I.L., Derrick, J.P. and Roberts, G.C.: Mapping the interactions between streptococcal protein G and the Fab fragment of IgG in solution.Nat. Struct. Biol. 1, 355-357 (1994).
6. Chhatre, S.: The integrated simulation and assessment of the impacts of process change in biotherapeutic antibody production. BiotechnoL Prog. 22, 1612-1620 (2006).
7. Chhatre, S.: A decision-support model for evaluating changes in biopharmaceutical manufacturing processes. Bioprocess Biosyst Eng. 30,1-11 (2007).
8. Li, R., Dowd, V., Stewart, D.J., Burton, S.J. and Lowe, C.R.: Design, synthesis, and application of a protein A mimetic. Nat. Biotechnol. 16, 190-195 (1998).
9. Kabir, S.: Immunoglobulin purification by affinity chromatography using protein A mimetic ligands prepared by combinatorial chemical synthesis. Immunol. Invest. 31, 263-278 (2002).
10. Newcombe, AR.: Optimised affinity purification ofpolyclonalantibodies from hyper immunised ovine serum using a synthetic Protein A adsorbent, MAbsorbent A2P. J. Chromatogr. B 814, 209-215 (2005).
11. Bak, H. and Thomas, OR.: Evaluation of commercial chromatographic adsorbents for the direct capture of polyclonal rabbit antibodies from clarified antiserum. J. Chromatogr. B 848, 116-130 (2007).
12. Birch, J.R. and Racher, A.J.: Antibody production. Adv. Drug Deliv. Rev. 58, 671-685 (2006).
13. Bonnerjea, J.: Purification of therapeutic proteins. Methods Mol. Biol. 244, 455-462 (2004).
14. Boschetti, E.: Antibody separation by hydrophobic charge induction chromatography. Trends Biotechnol. 20, 333-337 (2002).
15. Ghose, S., Hubbard, B. and Cramer, S.M.: Evaluation and comparison of alternatives to Protein A chromatography mimetic and hydrophobic charge induction chromatographic stationary phases. J. Chromatogr. A 1122, 144-152 (2006).
16. Newcombe, A.R.: Evaluation ofa biosensorassay to quantify polyclonalIgG in ovine serum used for the production of biotherapeutic antibody fragments. Process Biochem. 41, 842-847 (2006).